FE Healthcare Summit: Covaxin is outcome of complex science to achieve best efficacy, says Dr. Krishna Ella
Bharat Biotech has submitted its safety data to the Drugs Controller General of India (DCGI) based on the phase 2/3 clinical trials for manufacturing vaccine for children aged between 2 and 18. Bharat Biotech inactivated vaccine Covaxin is the outcome of complex scientific process that is needed to achieve best efficacy and immunogenicity, said Dr. … Read more